个人资料

博文分类

访客

最新评论

我的博文

Differential Crizotinib Efficacy among ROS1 Fusion Partners in ROS1-Positive Non-Small-Cell Lung Can

2017-06-23 02:34  阅读(210)  评论(0)  分类：专业

Differential Crizotinib Efficacy among ROS1 Fusion Partners in ROS1-Positive Non-Small-Cell Lung Can

From 2017 ASCO POSTER

 

上一篇：MET amplification(amp) is a major resistance mechanism to osimertinib-From 2017 ASCO POSTER
下一篇：BRAF Fusion in Clinically Advanced Non-small Cell Lung Cancer: An Emerging Target for anti-BRAF Ther

我要评论

共0条评论